JP2006511579A5 - - Google Patents

Download PDF

Info

Publication number
JP2006511579A5
JP2006511579A5 JP2004563642A JP2004563642A JP2006511579A5 JP 2006511579 A5 JP2006511579 A5 JP 2006511579A5 JP 2004563642 A JP2004563642 A JP 2004563642A JP 2004563642 A JP2004563642 A JP 2004563642A JP 2006511579 A5 JP2006511579 A5 JP 2006511579A5
Authority
JP
Japan
Prior art keywords
alkyl
group
halo
alkoxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004563642A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006511579A (ja
JP4516430B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/040129 external-priority patent/WO2004058149A2/en
Publication of JP2006511579A publication Critical patent/JP2006511579A/ja
Publication of JP2006511579A5 publication Critical patent/JP2006511579A5/ja
Application granted granted Critical
Publication of JP4516430B2 publication Critical patent/JP4516430B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004563642A 2002-12-20 2003-12-16 1−(アミノ)インダン並びに(1,2−ジヒドロ−3−アミノ)−ベンゾフラン、ベンゾチオフェン及びインドール Expired - Fee Related JP4516430B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43538102P 2002-12-20 2002-12-20
PCT/US2003/040129 WO2004058149A2 (en) 2002-12-20 2003-12-16 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles

Publications (3)

Publication Number Publication Date
JP2006511579A JP2006511579A (ja) 2006-04-06
JP2006511579A5 true JP2006511579A5 (cg-RX-API-DMAC7.html) 2006-10-12
JP4516430B2 JP4516430B2 (ja) 2010-08-04

Family

ID=32682229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004563642A Expired - Fee Related JP4516430B2 (ja) 2002-12-20 2003-12-16 1−(アミノ)インダン並びに(1,2−ジヒドロ−3−アミノ)−ベンゾフラン、ベンゾチオフェン及びインドール

Country Status (8)

Country Link
US (1) US7220734B2 (cg-RX-API-DMAC7.html)
EP (1) EP1581509B1 (cg-RX-API-DMAC7.html)
JP (1) JP4516430B2 (cg-RX-API-DMAC7.html)
AT (1) ATE496024T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003297232B2 (cg-RX-API-DMAC7.html)
CA (1) CA2509218C (cg-RX-API-DMAC7.html)
DE (1) DE60335827D1 (cg-RX-API-DMAC7.html)
WO (1) WO2004058149A2 (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004268455B2 (en) 2003-08-29 2009-12-17 Ono Pharmaceutical Co., Ltd. Compound capable of binding S1P receptor and pharmaceutical use thereof
US7605171B2 (en) 2003-12-17 2009-10-20 Merck & Co., Inc. (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
CN101905023B (zh) * 2004-07-16 2012-07-11 杏林制药株式会社 有效的医药使用方法及与副作用发生的防御相关的方法
BRPI0514316A (pt) 2004-08-13 2008-06-10 Praecis Pharm Inc métodos e composições para modulação de atividade de receptor de esfingosina-1-fosfato (s1p)
PL1806338T3 (pl) 2004-10-12 2016-07-29 Kyorin Seiyaku Kk Sposób wytwarzania chlorowodorku 2-amino-2-[2-[4-(3-benzyloksyfenylotio)-2-chlorofenyio]etylo]-1,3-propanodioiu i jego hydratów oraz produkty pośrednie w ich wytwarzaniu
ES2308127T3 (es) * 2004-10-22 2008-12-01 Bioprojet Nuevos derivados de acidos dicarboxilicos.
CA2591399C (en) 2004-12-13 2014-05-20 Ono Pharmaceutical Co., Ltd. Aminocarboxylic acid derivative and medicinal use thereof
WO2006090849A1 (ja) * 2005-02-25 2006-08-31 Redox Bioscience Inc. 炎症性眼表面疾患の予防ないし治療剤
WO2006115188A1 (ja) * 2005-04-22 2006-11-02 Daiichi Sankyo Company, Limited ヘテロ環化合物
SI1932522T1 (sl) * 2005-10-07 2012-08-31 Kyorin Seiyaku Kk Terapevtsko sredstvo za jetrno bolezen, ki vsebuje 2-amino-1,3- propandiolni derivat kot aktivno sestavino
PL1988083T3 (pl) 2006-02-03 2014-08-29 Taisho Pharmaceutical Co Ltd Pochodna triazolowa
TWI389683B (zh) * 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
RU2395499C2 (ru) 2006-02-06 2010-07-27 Тайсо Фармасьютикал Ко., Лтд. Ингибитор связывания сфингозин-1-фосфата
WO2007099423A1 (en) * 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
EP2003132B1 (en) * 2006-04-03 2014-03-05 Astellas Pharma Inc. Oxadiazole derivatives as S1P1 agonists
EP2017263A4 (en) 2006-05-09 2011-11-30 Daiichi Sankyo Co Ltd Heteroarylamide derivative of a lower carboxylic acid
RU2430925C2 (ru) 2006-08-08 2011-10-10 Киорин Фармасьютикал Ко., Лтд. Производное аминофосфата и модулятор рецептора s1p, содержащий его в качестве активного ингредиента
CA2659599C (en) 2006-08-08 2014-06-17 Kyorin Pharmaceutical Co., Ltd. Amino alcohol derivative and immunosuppressive agent having same as an active ingredient
JP2009269819A (ja) * 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物
EP2014653A1 (en) * 2007-06-15 2009-01-14 Bioprojet Novel dicarboxylic acid derivatives as S1P1 receptor agonists
ATE554070T1 (de) 2007-08-01 2012-05-15 Taisho Pharmaceutical Co Ltd Hemmer der s1p1-bindung
ES2655466T3 (es) 2007-08-13 2018-02-20 Monsanto Technology Llc Composiciones y procedimientos de control de nematodos
JP5452237B2 (ja) 2008-02-07 2014-03-26 杏林製薬株式会社 アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤
US20090298894A1 (en) * 2008-04-21 2009-12-03 Asahi Kasei Pharma Corporation Amino acid compounds
BRPI0912545B1 (pt) * 2008-05-14 2022-02-01 The Scripps Research Institute Compostos moduladores de receptores de esfingosina fosfato, uso dos mesmos e composição e combinação farmacêutica compreendendo os ditos compostos
PT2291080E (pt) 2008-05-14 2015-10-30 Scripps Research Inst Novos modelamodeladores dos recetores da esfingosina fosfato
CN104311472B9 (zh) 2008-07-23 2020-03-17 艾尼纳制药公司 经取代的1,2,3,4-四氢环戊并[b]吲哚-3-基乙酸衍生物
PL2342205T4 (pl) 2008-08-27 2016-12-30 Podstawione tricykliczne pochodne kwasowe jako antagoniści receptora S1P1 użyteczni w leczeniu zaburzeń autoimmunologicznych i zapalnych
WO2010085581A1 (en) 2009-01-23 2010-07-29 Bristol-Myers Squibb Company Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
EP2389377B1 (en) 2009-01-23 2014-07-16 Bristol-Myers Squibb Company Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
ES2405054T3 (es) 2009-01-23 2013-05-30 Bristol-Myers Squibb Company Derivados de pirazol-1,2,4-oxadiazol como agonistas de esfingosina-1-fosfato
US8399451B2 (en) 2009-08-07 2013-03-19 Bristol-Myers Squibb Company Heterocyclic compounds
HUE036391T2 (hu) * 2009-11-13 2018-07-30 Celgene Int Ii Sarl Szfingozin 1 foszfát receptor modulátorok és királis szintézis eljárások
PL2498610T5 (pl) * 2009-11-13 2024-11-04 Receptos Llc Selektywne modulatory receptora sfingozyno-1-fosforanu i sposoby syntezy chiralnej
CN105130922A (zh) * 2009-11-13 2015-12-09 瑞塞普托斯公司 选择性的杂环1-磷酸鞘氨醇受体调节剂
AU2010333338A1 (en) 2009-12-14 2012-08-02 Merck Patent Gmbh Sphingosine kinase inhibitors
EP2528894A1 (en) 2010-01-27 2012-12-05 Arena Pharmaceuticals, Inc. Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
CN105503882B (zh) 2010-03-03 2019-07-05 艾尼纳制药公司 制备s1p1受体调节剂及其晶体形式的方法
JP5735634B2 (ja) 2010-04-23 2015-06-17 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company スフィンゴシン−1−リン酸受容体1アゴニストとしての4−(5−イソオキサゾリルまたは5−ピラゾリル−1,2,4−オキサジアゾール−3−イル)−マンデル酸アミド化合物
WO2012040532A1 (en) 2010-09-24 2012-03-29 Bristol-Myers Squibb Company Substituted oxadiazole compounds and their use as s1p1 agonists
US9481659B2 (en) 2011-05-13 2016-11-01 Celgene International Ii Sàrl Selective heterocyclic sphingosine 1 phosphate receptor modulators
CA3002540C (en) 2015-01-06 2023-11-07 Arena Pharmaceuticals, Inc. Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
JP6838744B2 (ja) 2015-06-22 2021-03-03 アリーナ ファーマシューティカルズ, インコーポレイテッド S1P1レセプター関連障害における使用のための(R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸(化合物1)の結晶性L−アルギニン塩
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
KR20190113955A (ko) 2017-02-16 2019-10-08 아레나 파마슈티칼스, 인크. 장-외 증상을 갖는 염증성 장질환의 치료를 위한 화합물 및 방법
JP7397011B2 (ja) 2018-06-06 2023-12-12 アリーナ ファーマシューティカルズ, インコーポレイテッド S1p1受容体に関連する状態を治療する方法
EP3847158B1 (en) 2018-09-06 2026-06-24 Arena Pharmaceuticals, Inc. Compounds useful in the treatment of autoimmune and inflammatory disorders
CN116685313A (zh) 2020-12-23 2023-09-01 细胞基因公司 用于治疗神经变性疾病的含有茚满基的羧酸化合物
KR20240021883A (ko) 2021-06-16 2024-02-19 셀진 코포레이션 신경변성 질환의 치료를 위한 카르복실산 기를 포함하는 아제티디닐 화합물

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015583A1 (en) 1990-04-05 1991-10-17 The American National Red Cross A protein family related to immediate-early protein expressed by human endothelial cells during differentiation
US5585476A (en) 1994-02-15 1996-12-17 Maclennan; Alexander J. Molecular cloning and expression of G-protein coupled receptors
US6495579B1 (en) * 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US5912144A (en) 1997-04-24 1999-06-15 Incyte Pharmaceuticals, Inc. Edg-1-receptor homolog
US6060272A (en) 1997-05-07 2000-05-09 Human Genome Sciences, Inc. Human G-protein coupled receptors
CA2324972A1 (en) 1997-12-30 1999-07-15 Nps Allelix Corp. Identification of lysolipid receptors involved in inflammatory response
AU1955899A (en) 1997-12-30 1999-07-26 Nps Allelix Corp. Mammalian edg-7 receptor homologs
US6423508B1 (en) 1998-03-09 2002-07-23 Smithkline Beecham Corporation Polynucleotide sequences of human EDG-1c
WO1999054351A1 (en) 1998-04-23 1999-10-28 Smithkline Beecham Corporation Edg family gene, human h218
US6130067A (en) 1998-05-20 2000-10-10 Smithkline Beecham Corporation Human EDG3sb gene
JP2002531057A (ja) 1998-08-19 2002-09-24 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Edg受容体ファミリーに関連したgタンパク質結合受容体である14274受容体
AU6243499A (en) 1998-09-03 2000-03-27 Millennium Pharmaceuticals, Inc. 14275 receptor, a novel g-protein coupled receptor related to the edg receptor family
EP1112365A2 (de) 1998-09-11 2001-07-04 Max-Delbrück-Centrum Für Molekulare Medizin Humaner un muriner g-protein gekoppelter rezeptor edg6 (endothelial differentiation gen) und seine verwendung
ATE301673T1 (de) 1998-11-20 2005-08-15 Arena Pharm Inc Menschliche, an ein g-protein gekoppelter rezeptor rup3 ohne bekannten ligand
US6812335B1 (en) 1999-03-23 2004-11-02 The Regents Of The University Of California Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
WO2000060056A1 (en) 1999-04-05 2000-10-12 Smithkline Beecham Corporation Mouse edg5 gene
US6323333B1 (en) 1999-04-05 2001-11-27 Smithkline Beecham Corporation Mouse EDG1
PL351374A1 (en) * 1999-04-19 2003-04-07 Shionogi & Co Sulfonamide derivatives having oxadiazole rings
WO2001004139A2 (en) 1999-07-13 2001-01-18 Smithkline Beecham Corporation Human axor29 receptor
SE9902763D0 (sv) 1999-07-21 1999-07-21 Astra Pharma Inc Novel receptor
WO2001011022A1 (en) 1999-08-05 2001-02-15 Smithkline Beecham Corporation Mouse g-protein coupled receptor edg3
GB9923890D0 (en) 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
WO2001027137A2 (en) 1999-10-12 2001-04-19 Smithkline Beecham Corporation Rattus norvegicus (edg3)
WO2002059081A2 (en) * 2001-01-26 2002-08-01 Kirin Beer Kabushiki Kaisha Urea derivatives as inhibitors of ccr-3 receptor
EP1469863A2 (en) 2002-01-18 2004-10-27 Merck & Co., Inc. Selective s1p1/edg1 receptor agonists
DE60329073D1 (de) * 2002-01-18 2009-10-15 Merck & Co Inc Edg-rezeptoragonisten
ATE448193T1 (de) 2002-01-18 2009-11-15 Merck & Co Inc ßN-(BENZYL)AMINOALKYL CARBOXYLATE, PHOSPHINATE, PHOSPHONATE UND TETRAZOLE ALS EDG REZEPTORAGONISTENß
EP1482896A4 (en) 2002-03-01 2005-11-23 Merck & Co Inc AMINO ALKYL PHOSPHONATES AND RELATED COMPOUNDS AS EDG RECEPTOR AGONISTS
JP2005531506A (ja) 2002-03-01 2005-10-20 メルク エンド カムパニー インコーポレーテッド Edg受容体作動薬としてのアミノアルキルホスホネートおよび関連化合物
EP1549640A4 (en) 2002-06-17 2008-08-06 Merck & Co Inc 1 - ((5-ARYL-1,2,4-OXADIAZOL-3-YL) BENZYL) AZETIDINE-3-CARBOXYLATE AND 1 - ((5-ARYL-1,2,4-OXADIAZOL-3-YL) BENZYL) PYRROLIDIN-3-CARBOXYLATE AS EDG RECEPTOR AGONISTS

Similar Documents

Publication Publication Date Title
JP2006528980A5 (cg-RX-API-DMAC7.html)
CA2509218A1 (en) 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
JP2008517915A5 (cg-RX-API-DMAC7.html)
JP2007515432A5 (cg-RX-API-DMAC7.html)
EP3180319B1 (en) Novel pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection
JP2010540593A5 (cg-RX-API-DMAC7.html)
JP6813665B2 (ja) 4−ピリドン化合物またはその塩、それを含む医薬組成物および剤
CA2498051C (en) Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
AU2012312305B2 (en) Acyclic cyanoethylpyrazoles as janus kinase inhibitors
ES2271119T3 (es) Derivados de heterociclilalquilpiperidina, su preparacion y composiciones que contienen los mismos.
ES2649475T3 (es) Derivados de piridin-4-ilo
JP2013536235A5 (cg-RX-API-DMAC7.html)
ES2389042T3 (es) Compuestos de piridina
TW201010997A (en) Nicotinamide derivatives
RU2125565C1 (ru) Производные фенокси- или феноксиалкилпиперидина и антивирусная композиция на их основе
JP2002528490A5 (cg-RX-API-DMAC7.html)
JP2002528493A5 (cg-RX-API-DMAC7.html)
JP2009507909A5 (cg-RX-API-DMAC7.html)
HRP20211121T1 (hr) Supstituirani biciklični spojevi
CA2475712A1 (en) Nicotinamide derivatives useful as pde4 inhibitors
JP2015511614A (ja) B型肝炎ウイルス感染の治療および予防のための新規4−メチル−ジヒドロピリミジン
WO2014130310A1 (en) Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
CA2706991A1 (en) Heteroaryl-substituted piperidines
JP7408819B2 (ja) イソインドリン誘導体、並びにその医薬組成物及び使用
JP2014505723A5 (cg-RX-API-DMAC7.html)